The Patent Finder

Acid-Alpha Glucosidase Variants and Uses Thereof

Universite d'Evry Val d'Essonne

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/EP2017/072944, filed Sep 12, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,339,406Acid-Alpha Glucosidase Variants and Uses Thereof
In force
 · High confidence
Genethon, Inserm (Institut National de la Santé et de la Recherche Médicale), Universite d'Evry Val d'Essonne, Sorbonne Universite, Centre National de la Recherche Scientifique and Association Institut de MyologieIn force
High confidence
US 12,305,187Acid-Alpha Glucosidase Variants and Uses Thereof
In force
 · High confidence
Genethon, Inserm (Institut National de la Santé et de la Recherche Médicale), Universite d'Evry Val d'Essonne, Sorbonne Universite, Centre National de la Recherche Scientifique and Association Institut de MyologieIn force
High confidence
Application 19/208,730Acid-Alpha Glucosidase Variants and Uses Thereof
Pending
Not granted
Genethon, Inserm (Institut National de la Santé et de la Recherche Médicale), Universite d'Evry Val d'Essonne, Sorbonne Universite, Centre National de la Recherche Scientifique and Association Institut de MyologiePendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Universite d'Evry Val d'Essonne.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited